Whitney & Co’s Encompass Health EHC Stock Holding History

Whitney & Co’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19	Closed	-$1K	–	204
2018 Q3	$1K	Buy	+19	New	+$1.16K	﹤0.01%	500

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Whitney & Co's EHC Position: Q4 2018 in Review

Whitney & Co sold out of Encompass Health (EHC) in Q4 2018, closing a stake of 19 shares — an estimated $1K sold.

Whitney & Co first reported a position in EHC in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 447 funds tracked by Wall St. Rank hold EHC as of Q4 2018.

Whitney & Co reported no remaining Encompass Health position as of Q4 2018 after selling out during the quarter.
Whitney & Co sold 19 Encompass Health shares in Q4 2018, an estimated $1K.
Whitney & Co first reported a position in Encompass Health in Q3 2018 and held it in 1 quarter.
Whitney & Co's Encompass Health position peaked at $1K in Q3 2018.
447 funds tracked by Wall St. Rank held Encompass Health as of Q4 2018.

Based on Whitney & Co's 13F filing for Q4 2018, filed 7 Feb 2019.